Novartis, Roche, AstraZeneca, Sanofi Winners In 2013: China Big Pharma Roundup
This article was originally published in PharmAsia News
Executive Summary
Impacted by compliance issues, Big Pharma’s growth slowed in China. However, Novartis, Roche, AstraZeneca and Sanofi actually gained market share for the year.